Search results (113 results)

Aug 27 2024 by Monica Elena Cortizo Brown , MD

72 year old female with long-term use of hydroxichloroquine for more than 5 years with parafoveal retinal pigment atrophy and “Bull's eye maculopathy”

Photographer: Mónica Elena Cortizo, Hospital de la Luz, Ciudad de México

Condition/keywords: Hidroxychloroquine maculopathy, Medication toxicity

Feb 12 2024 by BENITO VERGARA, MD

Image of a late phase fluorescein angiography at 4 minutes and 30 seconds of a 58-year-old woman treated with chloroquine at a daily dose of 3mg/kg, (recommended dose >2.3 mg/kg) that shows circular window defect suggestive of bullseye maculopathy.

Photographer: Benito Vergara Flores.

Imaging device: Clarus 700

Condition/keywords: chloroquine toxicity

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Mar 31 2023 by Niloofar Piri, MD

Fundus autofluorescence image of the right eye in a highly myopic Caucasian patient who was screened for plaquenil toxicity elsewhere for 15 years. Medicine was stopped 3 years ago. She presented to us with deteriorationg central vision and scotoma for the past 3 years. FAF demonstrtaes classic symmetric bull's eye pattern of hypoautofluorescence in parafoveal area both eyes with some extension to the arcades, which is the result of severe plaquenil toxicity. Notice the hyperAF area surrounding the bull'e eye which is demonstarting stressed RPE cells filled with Lipofuscin. This area will likely turn to a larger hypoAF later. It is critical to diagnose it early to prevent the ongoing damage and loss of RPE and photoreceptors from the long term deposited medicine in RPE cells.

Photographer: Sean Kelso, Saint Lousi University

Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity

Jan 22 2023 by Maxwell J Wingelaar, MD

A 50-year-old woman with a prior history of hydroxychloroquine use that developed bull's eye maculopathy

Photographer: Jarrod Wehmeier

Condition/keywords: bull's eye maculopathy

Jan 22 2023 by Maxwell J Wingelaar, MD

A 50-year-old woman with a prior history of hydroxychloroquine use that developed bull's eye maculopathy

Photographer: Jarrod Wehmeier

Condition/keywords: bull's eye maculopathy

Jan 22 2023 by Maxwell J Wingelaar, MD

A 50-year-old woman with a prior history of hydroxychloroquine use that developed bull's eye maculopathy

Photographer: Jarrod Wehmeier

Condition/keywords: bull's eye maculopathy

Jan 22 2023 by Maxwell J Wingelaar, MD

A 50-year-old woman with a prior history of hydroxychloroquine use that developed bull's eye maculopathy

Photographer: Jarrod Wehmeier

Condition/keywords: bull's eye maculopathy

Jun 22 2022 by JORGE SOBERANES

Fundus autofluorescence of a bull´s eye maculopathy of a 55-year-old woman treated for ten years with choloquine.

Photographer: Jorge I. Soberanes MD, Asociación para Evitar la Ceguera en México.

Imaging device: Zeiss Clarus 700 (Green autofluorescence)

Condition/keywords: bull's eye maculopathy, chloroquine, fundus autofluorescence (FAF), macula, maculopathy

Feb 25 2021 by Niloofar Piri, MD

SD- OCT of the same patient with hydroxychloroquine (Plaquenil) toxicity, demonstrating classic "Flying Saucer" pattern secondary to parafoveal RPE atrophy, and outer retinal layer disruption including EZ loss, and outer nuclear layer loss.

Condition/keywords: bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity

Feb 25 2021 by Niloofar Piri, MD

Bilateral fundus autofluorescence of a patient with hydroxycholoroquine (plaquenil) toxicity demonstrating classic bull's eye pattern.

Condition/keywords: bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity

Mar 26 2019 by Gary R. Cook, MD, FACS

Mid-venous phase FA frame from a 61-year-old white female with a Bull's-eye maculopathy OS secondary to Plaquenil toxicity; VA= 20/30.

Imaging device: Topcon VT-50

Condition/keywords: bull's eye atrophy, bull's eye maculopathy, fluorescein angiogram (FA), hydroxychloroquine toxicity, plaquenil toxicity

Mar 26 2019 by Gary R. Cook, MD, FACS

61-year-old white female with a Bull's-eye maculopathy OS secondary to Plaquenil toxicity; VA= 20/30.

Imaging device: Topcon VT-50

Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity

Mar 26 2019 by Gary R. Cook, MD, FACS

3-minute mid-venous phase FA frame from a 61-year-old white female with a Bull's-eye maculopathy OD secondary to Plaquenil toxicity; VA=20/40.

Imaging device: Topcon VT-50

Condition/keywords: bull's eye atrophy, bull's eye maculopathy, fluorescein angiogram (FA), hydroxychloroquine toxicity, plaquenil toxicity

Mar 26 2019 by Gary R. Cook, MD, FACS

61-year-old white female with Bull's-eye maculopathy OD secondary to plaquenil toxicity; VA= 20/40.

Imaging device: Topcon VT-50

Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity

Feb 26 2019 by Lancaster Course in Ophthalmology

One side of the ring of chloroquine macular degeneration shows a loss of the photoreceptor cell layer, and pigmented cells cling to and minimally infiltrate the outer aspect of the retina.

Condition/keywords: macular degeneration, photoreceptor cell

Dec 21 2016 by Young Hee Yoon, MD, PhD

Wide auto-fluorescence photograph of an 47-year-old woman with pericentral HCQ (hydroxychloroquine) toxicity (right eye).

Photographer: Kyung Woon Kim, Asan Medical Center

Imaging device: Wide Auto fluorescence photograph

Condition/keywords: pericentral HCQ (hydroxychloroquine) toxicity

Dec 21 2016 by Young Hee Yoon, MD, PhD

Wide auto-fluorescence photograph of an 47-year-old woman with pericentral HCQ (hydroxychloroquine) toxicity (left eye).

Photographer: Kyung Woon Kim, Asan Medical Center

Imaging device: Wide Auto fluorescence photograph

Condition/keywords: pericentral HCQ (hydroxychloroquine) toxicity